Related Experiment Video
Updated: Apr 13, 2026

08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
5.6K
Precision and predictive medicine in urothelial cancer: are we making progress?
Joaquim Bellmunt1, Anna Orsola1, Guru Sonpavde2
1Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
European Urology
|May 4, 2015
Abstract:
Therapy for urothelial carcinoma appears poised for a breakthrough on the basis of information regarding molecular subtypes and promising activity of PD-1/PD-L1 inhibitors. Precision medicine may be possible using rational marker-driven trial designs with enriched information from tumor genotyping and extreme responders.

